Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
BMJ Open
|
June 10, 2018
Evaluation of different infant vaccination schedules incorporating pneumococcal vaccination (The Vietnam Pneumococcal Project): protocol of a randomised controlled trial
Beth Temple, Nguyen Trong Toan, Doan Y Uyen, et al.
Frontiers in Pediatrics
|
May 9, 2015
Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trial
Gabrielle B McCallum, Peter S Morris, Keith Grimwood, et al.
Vaccine: X
|
March 8, 2021
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal <i>Haemophilus influenzae</i> protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial
Amanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, et al.
BMJ Open
|
May 26, 2020
10-Valent pneumococcal non-typeable <i>H. influenzae</i> protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial
Victor M Oguoma, Nicole Wilson, Kim Mulholland, et al.
Journal of the American Medical Directors Association
|
April 6, 2021
The 4-DSD: A New Tool to Assess Delirium Superimposed on Moderate to Severe Dementia
Alessandro Morandi, Eleonora Grossi, Elena Lucchi, et al.
Human Vaccines & Immunotherapeutics
|
June 27, 2018
The clinical, immunological and microbiological impact of the 10-valent pneumococcal-Protein D conjugate vaccine in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: A multi-centre, double-blind, randomised controlled trial
Kerry-Ann F O'Grady, Anne B Chang, Allan Cripps, et al.
The Lancet. Respiratory Medicine
|
August 21, 2019
Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial
Vikas Goyal, Keith Grimwood, Robert S Ware, et al.
BMJ Open
|
April 27, 2019
HOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trial
Anne B Chang, Siew Moy Fong, Tsin Wen Yeo, et al.
Cytokine
|
December 24, 2025
Relationship between IL-17_A and pneumococcal carriage in children aged under two years: data from a randomised controlled trial in Vietnam
Zheng Quan Toh, Yi Ying Ma, Beth Temple, et al.
Microbiology Spectrum
|
January 16, 2023
Impact of COVID-19 Nonpharmaceutical Interventions on Pneumococcal Carriage Prevalence and Density in Vietnam
Monica Larissa Nation, Sam Manna, Hau Phuc Tran, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
BMJ Open
|
June 10, 2018
Evaluation of different infant vaccination schedules incorporating pneumococcal vaccination (The Vietnam Pneumococcal Project): protocol of a randomised controlled trial
Beth Temple, Nguyen Trong Toan, Doan Y Uyen, et al.
Frontiers in Pediatrics
|
May 9, 2015
Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trial
Gabrielle B McCallum, Peter S Morris, Keith Grimwood, et al.
Vaccine: X
|
March 8, 2021
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal <i>Haemophilus influenzae</i> protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial
Amanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, et al.
BMJ Open
|
May 26, 2020
10-Valent pneumococcal non-typeable <i>H. influenzae</i> protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial
Victor M Oguoma, Nicole Wilson, Kim Mulholland, et al.
Journal of the American Medical Directors Association
|
April 6, 2021
The 4-DSD: A New Tool to Assess Delirium Superimposed on Moderate to Severe Dementia
Alessandro Morandi, Eleonora Grossi, Elena Lucchi, et al.
Human Vaccines & Immunotherapeutics
|
June 27, 2018
The clinical, immunological and microbiological impact of the 10-valent pneumococcal-Protein D conjugate vaccine in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: A multi-centre, double-blind, randomised controlled trial
Kerry-Ann F O'Grady, Anne B Chang, Allan Cripps, et al.
The Lancet. Respiratory Medicine
|
August 21, 2019
Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial
Vikas Goyal, Keith Grimwood, Robert S Ware, et al.
BMJ Open
|
April 27, 2019
HOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trial
Anne B Chang, Siew Moy Fong, Tsin Wen Yeo, et al.
Cytokine
|
December 24, 2025
Relationship between IL-17_A and pneumococcal carriage in children aged under two years: data from a randomised controlled trial in Vietnam
Zheng Quan Toh, Yi Ying Ma, Beth Temple, et al.
Microbiology Spectrum
|
January 16, 2023
Impact of COVID-19 Nonpharmaceutical Interventions on Pneumococcal Carriage Prevalence and Density in Vietnam
Monica Larissa Nation, Sam Manna, Hau Phuc Tran, et al.
Page
of 8